Registered Malawi · PMRA

KCHEK 15G POWDER

CALCIUM POLYSTRENE SULPHATE

PMPB/PL498/3 POWDER

What it does

Polystrene is used to help remove excess potassium from the body, which can occur in conditions like kidney disease.

Commonly used for: high potassium levels (hyperkalemia)

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Medicine sourcing is available in Kenya only. We don't sell or dispense medicines - licensed pharmacies do.

Sourcing - Kenya only

Registration & product details

Registration no.
PMPB/PL498/3
Registration date
13/09/2018
Expiry date
31/03/2023
Status
Registered
Active ingredient
CALCIUM POLYSTRENE SULPHATE
Dosage form
POWDER
Strength
-
Pack size
-
Therapeutic class
-
Manufacturer / MAH
-
Applicant / LTR
-
Country of origin
-

Source: Pharmacy and Medicines Regulatory Authority · fetched 2026-04-21 17:37:45 · updated 2026-09-29 04:33:06

Disclaimer: This information is sourced from Pharmacy and Medicines Regulatory Authority (Malawi). Always consult a qualified healthcare professional before using any medication.

About this medicine

Polystrene is used to help remove excess potassium from the body, which can occur in conditions like kidney disease.

What it treats

  • high potassium levels (hyperkalemia)

How it works

Polystrene works by binding to potassium in the intestines, helping the body get rid of it through stool.

Who it's for

This medication is for adults and children with high potassium levels due to kidney problems or other health issues.

Cautions

  • • Consult your doctor if you have bowel problems or other serious health conditions.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: polystrene

Polystyrene sulfonate, commonly referred to as polystyrene, is a cation exchange resin used primarily for the treatment of hyperkalemia, a condition characterized by elevated levels of potassium in the blood. It works by exchanging sodium ions for potassium ions in the gastrointestinal tract, thereby reducing serum potassium levels. The drug is often administered orally or rectally and is typically used in conjunction with other treatments for effective management of potassium levels.

Indications

  • Hyperkalemia
  • Management of high potassium levels in patients with renal impairment

Dosage

Children: Refer to BNF for Children for specific dosing guidelines.

Adults: Refer to BNF for specific dosing guidelines.

Mechanism of action

Polystyrene sulfonate functions as a cation exchange resin. It binds potassium ions in the gastrointestinal lumen and exchanges them for sodium ions, facilitating the excretion of potassium through feces. This mechanism helps to lower serum potassium levels in patients with hyperkalemia.

Pharmacodynamics

The pharmacodynamics of polystyrene sulfonate involve its ability to lower serum potassium concentrations through ion exchange. The onset of action can vary, but therapeutic effects are usually observed within hours to days depending on the route of administration and the severity of hyperkalemia. The drug does not promote renal excretion of potassium but rather works through gastrointestinal elimination.

Pharmacokinetics

Polystyrene sulfonate is not absorbed systemically, as it remains in the gastrointestinal tract where it exerts its effects. The drug's action is localized, and its effects can be influenced by gastrointestinal transit time. The half-life is not applicable since it is not metabolized or absorbed. The primary route of elimination is fecal excretion, following the exchange of potassium for sodium.

Contra-indications

  • Hypersensitivity to polystyrene sulfonate or any of its components
  • Severe intestinal obstruction
  • Colonic necrosis

Adverse effects

  • Gastrointestinal disturbances (e.g., constipation, diarrhea)
  • Electrolyte imbalances (e.g., hypokalemia)
  • Nausea and vomiting
  • Abdominal pain
  • Intestinal necrosis
  • Bowel perforation

Interactions

  • May interact with other medications that affect electrolyte levels
  • Caution with concurrent use of potassium-sparing diuretics
  • Potential interaction with digoxin and other cardiac glycosides

Precautions

  • Use with caution in patients with heart failure or renal impairment
  • Monitor serum electrolytes regularly
  • Ensure adequate hydration to prevent constipation
  • Assess for signs of intestinal obstruction

Pregnancy

The safety of polystyrene sulfonate in pregnancy has not been established. Use only if clearly needed.

Breast-feeding

Polystyrene sulfonate is not expected to harm a nursing infant. However, consult with a healthcare provider before use.

Storage

Store at room temperature, away from moisture and heat. Keep out of reach of children.

Formulations

  • Powder for oral suspension
  • Enema

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.